Welcome to the Iranian Journal of Radiology, a pivotal platform dedicated to advancing the field of radiology, nuclear medicine, and medical imaging. Published by BRIEFLAND, this journal aims to disseminate high-quality original research, reviews, and clinical studies that contribute substantially to the global scientific community. Established in 2008 and spanning until 2024, the journal provides an essential archive of knowledge in a rapidly evolving discipline. Although it currently holds a Q4 quartile ranking in the 2023 Scopus metrics, it serves as an important resource for both emerging and established researchers looking to submit their work. Located in the Netherlands, the journal is committed to open dialogue and collaboration amongst professionals in the field, reflecting its accessibility and relevance to both practitioners and academics. With its continued growth and commitment to quality, the Iranian Journal of Radiology is poised to enhance understanding and innovation in diagnostic imaging.

Oncology Reviews, founded in 2007 and published by FRONTIERS MEDIA SA, is a leading open-access journal dedicated to advancing knowledge in the field of oncology and cancer research. With an Impact Factor reflecting its robust engagement in scholarly discourse, this journal maintains a prestigious standing, earning a Q2 ranking in Oncology and a Q3 ranking in Cancer Research as of 2023. Notably, it is indexed in Scopus, where it ranks #118 in Oncology and #98 in Cancer Research, highlighting its global reach and significance. The journal's open-access policy, in effect since 2012, ensures that high-quality research is accessible to all, fostering collaboration and wellness improvements worldwide. This commitment to accessibility and dissemination of pivotal research makes Oncology Reviews an essential resource for researchers, healthcare professionals, and students eager to contribute to and stay abreast of the latest innovations in cancer treatment and research.

Radiation Oncology Journal, published by the Korean Society of Therapeutic Radiology & Oncology, stands at the forefront of cancer treatment research and innovation within the dynamic fields of oncology and radiology. With a focus on disseminating groundbreaking findings and advancements from 2012 to 2024, this journal aims to foster collaboration among researchers, clinicians, and educators dedicated to improving therapeutic techniques and patient outcomes in the context of radiation therapy. Recognized with a prestigious Q2 ranking in both the Oncology and Radiology, Nuclear Medicine and Imaging categories, it ranks 140th out of 333 in its Scopus category for Medicine Radiology and boasts a 58th percentile placement. While operating on a non-open access basis, the journal remains committed to providing valuable insights and updates to professionals in the field from its base in South Korea. As the landscape of cancer treatment evolves, the Radiation Oncology Journal continues to play a vital role in shaping research trends and enhancing the understanding of radiotherapy's role in comprehensive cancer care.

Case Reports in Oncological Medicine is a distinguished open-access journal published by HINDAWI LTD, dedicated to disseminating valuable insights and findings in the field of oncology. Since its inception in 2011, this journal has aimed to provide a unique platform for the publication of detailed case reports that contribute to our understanding of cancer diagnosis, treatment, and management. With a specific focus on sharing clinical experiences and outcomes, it seeks to engage researchers, healthcare professionals, and students who are committed to advancing oncological knowledge and improving patient care. Although coverage in Scopus was discontinued from 2014 to 2017, the journal currently holds a rank of #232/323 in Medicine - Oncology, placing it within the 28th percentile. Researchers interested in making their work accessible can benefit from the journal's open-access model, allowing greater visibility and citation potential within the scientific community. The journal is positioned as an important resource for those looking to stay updated on the latest case studies and innovations in oncological medicine.

Ocular Oncology and Pathology is a distinguished journal dedicated to the multifaceted study of ocular diseases, particularly focusing on oncology and pathology. Published by KARGER, a reputable publisher based in Switzerland, this journal serves as a vital resource for researchers, clinicians, and students in the fields of ophthalmology, pathology, and oncology. With an ISSN of 2296-4681 and an E-ISSN of 2296-4657, the journal has established itself as a significant contributor to the literature, achieving a commendable ranking of 55th out of 139 in the General Nursing category within Scopus, placing it in the 60th percentile. Now converging its expertise until 2024, Ocular Oncology and Pathology aims to publish high-quality, peer-reviewed research articles that advance the understanding of ocular neoplasms and their pathological features. The journal’s commitment to open access promotes the dissemination of vital scientific knowledge, ensuring worldwide accessibility to high-impact research, making it an essential platform for the academic community.

Practical Radiation Oncology is a premier journal published by Elsevier Science Inc., focusing on the critically important fields of Oncology and Radiology, Nuclear Medicine, and Imaging. With an ISSN of 1879-8500, this journal serves as an essential resource for professionals and researchers dedicated to advancing the practice and research of radiation oncology. Established in 2011 and continuing through 2024, it has quickly gained recognition, achieving a prestigious Q2 ranking in Oncology and an exceptional Q1 ranking in Radiology, Nuclear Medicine, and Imaging as of 2023. The journal, housed in New York, USA, provides a platform for innovative research and practical insights, aimed at enhancing therapeutic practices and improving patient outcomes. As part of its commitment to fostering scientific dialogue, it also features a range of articles, reviews, and clinical studies that cater to the diverse interests of its readers. Hard-copy availability combined with digital access ensures a broad reach for the latest advancements in the field.

Clinical Genitourinary Cancer, published by CIG MEDIA GROUP, LP, is a leading journal in the fields of Oncology and Urology, with an impressive impact reflected in its quartile rankings (Q2 in Oncology and Q1 in Urology for 2023) and strong Scopus rankings (22nd in Urology and 162nd in Oncology). The journal aims to innovate and inspire new research in genitourinary malignancies, providing a platform for the latest findings in diagnosis, treatment, and patient management. With its commitment to high-quality publications since its establishment in 2005, Clinical Genitourinary Cancer serves a crucial role in advancing the understanding of these complex conditions and enhancing clinical practices. Researchers, professionals, and students in the medical community are encouraged to engage with this essential resource, which facilitates open access to pioneering studies that drive the field forward.

Cancer Radiotherapie, published by Elsevier, is a respected academic journal dedicated to advancing the field of oncology and radiology through original research and comprehensive reviews. With an ISSN of 1278-3218 and an E-ISSN of 1769-6658, the journal serves as a vital platform for disseminating knowledge and innovation in cancer treatment methodologies, specifically focusing on radiotherapy. As of 2023, it holds a Category Quartile of Q3 in both Oncology and Radiology, Nuclear Medicine and Imaging, reflecting its significance within these domains amidst a competitive landscape. Despite its current rankings—205th out of 333 in Radiology and 269th out of 404 in Oncology—it continuously strives to build a reputable presence with contributions that push the boundaries of cancer therapy. Although open access options are not available, the journal is committed to ensuring that valuable insights reach healthcare professionals and researchers worldwide, contributing to improved patient outcomes and advancements in treatment efficacy.

Reports of Practical Oncology and Radiotherapy is a distinguished open-access journal dedicated to advancing the fields of oncology, radiotherapy, and cancer research. Published by VIA MEDICA since 2001, this journal serves as a critical platform for disseminating innovative research and practical findings that impact clinical practices and patient outcomes. With an emphasis on fostering collaboration and knowledge exchange among researchers, clinicians, and students, the journal has positioned itself within the Q3 and Q4 categories of renowned directories in oncology, radiology, and nuclear medicine as of 2023. Based in Gdansk, Poland, it provides unrestricted access to its articles, ensuring that crucial research reaches a wide audience. This dedication to open access reflects the journal's commitment to transparency and innovation in the fight against cancer, making it an invaluable resource in this vital field of study.

Radiotherapy and Oncology is a leading peer-reviewed journal published by Elsevier Ireland Ltd, focusing on the vital fields of hematology, oncology, and radiology. With an impressive impact factor and ranking in the top quartiles (Q1) of its categories as of 2023, it is recognized for disseminating high-quality research that contributes significantly to advancements in cancer treatment and patient care. The journal, which has been in circulation since 1983, aims to provide a platform for original research articles, reviews, and clinical studies that explore the latest innovations in radiotherapeutic technologies and oncology practices. This journal is essential for researchers, healthcare professionals, and students who are dedicated to improving cancer therapies and outcomes. Although it does not offer open access, the wealth of information contained within its pages supports continued education and development in these crucial medical fields.